# SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

> **NCT00503867** · NA · TERMINATED · sponsor: **Sirtex Medical** · enrollment: 10 (actual)

## Conditions studied

- Carcinoma, Hepatocellular
- Hepatoma

## Interventions

- **DEVICE:** SIR-Spheres microspheres

## Key facts

- **NCT ID:** NCT00503867
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07-18
- **Primary completion:** 2010-03-09
- **Final completion:** 2010-03-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low patient recruitment
- **Last updated:** 2020-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503867, "SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00503867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*